page contents

Tag Archives: Solid

CLR 131 Found to Broadly Target Pediatric Solid Tumors

According to a new study by UW Carbone Cancer Center (UWCCC) researchers, a broadly applicable cancer therapy currently being developed by Cellectar Biosciences may have the potential to work in pediatric solid tumors. CLR 131 (formerly known as CLR1404) delivers high doses of cell-killing radioactive iodine specifically to cancer cells. It could become the first targeted, molecular radiotherapy to be tested in ...

Read More »

Live Nation Posts Solid Second-Quarter Earnings

Live Nation, the world’s largest live-entertainment company, announced its Q2 2017 financial report Wednesday afternoon, and it showed revenue increasing 29% over the same quarter in 2016 to $ 2.8 billion, with operating income up 53% to $ 113 million, and adjusted operating income (AOI) rising 22% to $ 221 million. Live Nation President/CEO

Read More »